Cohen David E
SEC Form 4 insider trading activity
Cohen David E has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 3, 2026.
On the most recent filing, Cohen David E is listed as Director at Evommune, Inc. Inside the rolling window, Cohen David E reported no open-market purchases and 1 open-market sale totaling $123K in EVMN.
Companies traded
Other insiders at EVMN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$123K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cohen David E made?
Cohen David E has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Cohen David E trade?
Cohen David E has filed SEC Form 4 disclosures for 1 company, including EVMN.
When was Cohen David E's most recent SEC Form 4 filing?
Cohen David E's most recent SEC Form 4 filing on Tracefour is dated Jun 3, 2026.
What is Cohen David E's total buy and sell value in the current window?
Inside the rolling retention window, Cohen David E bought $0 and sold $123K based on SEC Form 4 filings.
What was Cohen David E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,056 EVMN shares on 2026-06-02, worth $123K, per SEC Form 4 filings.